About Tony Kalajian
Tony Kalajian is a chief accounting officer at Beyond Meat.
Form D filings name Tony Kalajian as an interim chief financial officer at Calidi Biotherapeutics.
Tony Kalajian reports to the SEC as an officer of 3 public companies, including Calidi Biotherapeutics (CLDI) and Insight Molecular Diagnostics (IMDX).
Tony Kalajian first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Tony Kalajian in the role, so the role may have started earlier or lasted longer.
BI
Beyond Meat, Inc.
Chief Accounting Officer
2026 · Public company (BYND)
II
Insight Molecular Diagnostics Inc.
Sr.VP/Chief Accounting Officer
2019 – 2020 · Public company (IMDX)
Key Colleagues at Startups
The people Tony Kalajian works with at each company, as listed on that company's latest Form D.
Calidi Biotherapeutics, Inc. · Form D, Jun 29, 2023
AC
Allan Camaisa
CEO and director
HL
Heehyoung Lee
Director
JS
James Schoeneck
Director
AZ
Alfonso Zulueta
Director
AS
Anthony Santidrian
Executive officer
BM
Boris Minev
Interim Chief Medical Officer
ST
Stephen Thesing
Chief Business Officer
AP
Amish Patel
Vice President of Technical Operations
DS
David Sans
Chief of Corporate Development
WP
Wendy Pizarro
Executive officer
SL
Scott Leftwich
Director
GN
George Ng
Director